Dianthus Therapeutics | MGTA - 营业利润



金融业
股票价格
USD
资产
USD 530.92M
现金及等价物
USD 51.09M
流动资产
USD 409.44M
流动负债
USD 30.73M
债务
USD 1.29M
EBIT
USD -40.29M
EBITDA
USD -40.19M
员工
53
EPS每股收益
USD -0.97
股本和储备
USD 493.4M
销售毛利
USD 396K
债务利息支出
USD 4.45M
利息收入
USD 3.66M
贷款资金
USD 0
市值
USD 2.29B
净收入
USD -36.76M
营业费用
USD 40.68M
营业利润
USD -40.29M
普通股股本
USD 42.85M
税前利润
USD -36.76M
销售收入
USD 396K
销售和管理费用
USD 8.2M
股票
384K
贸易债权人
USD 9.73M
应收帐款人
USD 5M


营业利润 更改 日
Akebia Therapeutics USD 13.51M 27.82M 2025-03
Alaunos Therapeutics USD -1.19M 432K 2025-09
Avita Medical AUD -10.41M 742K 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Cspc Pharmaceutical CNY 1.22B 60.54M 2025-09
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Divis Laboratories Ltd INR 7.72B 30M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Knight Therapeutics CAD 2.94M 2.4M 2025-09
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Moderna USD -857M 597M 2025-12
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Organigram Holdings CAD -28.05M 7.76M 2025-09
Organon & Co USD 388M 62M 2025-09
Ovoca Bio EUR -5.65M 3.45M 2022-06
Pharma Mar EUR 43.61M 47.57M 2025-12
Qiagen NV USD 121.88M 15.41M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tectonic Therapeutic USD -21.89M 440K 2025-09
Tilray USD -20.01M 9.34M 2025-09
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 6.73M 2.25M 2025-09
Zz Pientze Pharmaceu CNY 501.33M 52.54M 2025-09